{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:59:16Z","timestamp":1787068756627,"version":"build-2736575974"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Pharm Bioall Sci"],"published-print":{"date-parts":[[2017]]},"DOI":"10.4103\/jpbs.jpbs_308_16","type":"journal-article","created":{"date-parts":[[2017,5,15]],"date-time":"2017-05-15T04:27:49Z","timestamp":1494822469000},"page":"56","source":"Crossref","is-referenced-by-count":3,"title":["Efficacy and tolerability of antihypertensive drugs in diabetic and nondiabetic patients"],"prefix":"10.4103","volume":"9","author":[{"given":"Maria","family":"Aslam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mobasher","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fizza","family":"Mobasher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0975-7406.206221-1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0140-6736(05)17741-1","article-title":"Global burden of hypertension: Analysis of worldwide data","author":"Kearney","year":"2005","journal-title":"Lancet"},{"key":"key-10.4103\/0975-7406.206221-2","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1631\/jzus.B1101001","article-title":"Target blood pressure in diabetes patients with hypertension \u2013 What is the accumulated evidence in 2011?","author":"Nilsson","year":"2011","journal-title":"J Zhejiang Univ Sci B"},{"key":"key-10.4103\/0975-7406.206221-3","first-page":"601380","article-title":"The management of type 2 diabetic patients with hypoglycemic agents","author":"Carnevale","year":"2012","journal-title":"ISRN Endocrinol"},{"key":"key-10.4103\/0975-7406.206221-4","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s11883-012-0227-2","article-title":"Diabetes and hypertension: Is there a common metabolic pathway?","author":"Cheung","year":"2012","journal-title":"Curr Atheroscler Rep"},{"key":"key-10.4103\/0975-7406.206221-5","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.2337\/db12-0225","article-title":"Genetic predisposition to high blood pressure associates with cardiovascular complications among patients with type 2 diabetes: Two independent studies","author":"Qi","year":"2012","journal-title":"Diabetes"},{"key":"key-10.4103\/0975-7406.206221-6","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0828-282X(09)70493-3","article-title":"Hypertension in diabetes: A call to action","author":"Campbell","year":"2009","journal-title":"Can J Cardiol"},{"key":"key-10.4103\/0975-7406.206221-7","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1186\/1471-2458-10-529","article-title":"Epidemiological and economic burden of metabolic syndrome and its consequences in patients with hypertension in Germany, Spain and Italy; a prevalence-based model","author":"Scholze","year":"2010","journal-title":"BMC Public Health"},{"key":"key-10.4103\/0975-7406.206221-8","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2147\/VHRM.S4331","article-title":"Prevention of diabetes in hypertensive patients: Results and implications from the VALUE trial","author":"Zhou","year":"2009","journal-title":"Vasc Health Risk Manag"},{"key":"key-10.4103\/0975-7406.206221-9","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":", et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure","author":"Chobanian","year":"2003","journal-title":"Hypertension"},{"key":"key-10.4103\/0975-7406.206221-10","doi-asserted-by":"crossref","first-page":"531","DOI":"10.4103\/IJMR.2010_132_05_531","article-title":"Strategies for initial management of hypertension","author":"Gupta","year":"2010","journal-title":"Indian J Med Res","ISSN":"https:\/\/id.crossref.org\/issn\/0971-5916","issn-type":"print"},{"key":"key-10.4103\/0975-7406.206221-11","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":", et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"key-10.4103\/0975-7406.206221-12","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease","author":"Kidney","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"key-10.4103\/0975-7406.206221-13","first-page":"990","article-title":"Standards of medical care in diabetes","author":"American","year":"2005","journal-title":"Diabetes Care"},{"key":"key-10.4103\/0975-7406.206221-14","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.cjca.2012.02.018","article-title":"The 2012 Canadian hypertension education program recommendations for the management of hypertension: Blood pressure measurement, diagnosis, assessment of risk, and therapy","author":"Daskalopoulou","year":"2012","journal-title":"Can J Cardiol"},{"key":"key-10.4103\/0975-7406.206221-15","first-page":"21","article-title":"Efficacy and tolerability of different antihypertensive drugs in diabetic patients with mild to moderate hypertension in a multi speciality hospital \u2013 A prospective comparative study","author":"Beulah","year":"2011","journal-title":"Indian J Pharm Pract"},{"key":"key-10.4103\/0975-7406.206221-16","first-page":"436","article-title":"Efficacy and tolerability of different antihypertensive drugs in patients with mild to moderate hypertension in a tertiary Care hospital \u2013 A prospective, comparative study","author":"Yasmeen","year":"2011","journal-title":"Arch Appl Sci Res"},{"key":"key-10.4103\/0975-7406.206221-17","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.clinthera.2011.08.008","article-title":"Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management","author":"Petrella","year":"2011","journal-title":"Clin Ther"},{"key":"key-10.4103\/0975-7406.206221-18","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.clinthera.2012.06.026","article-title":"I-COMBINE study: Assessment of efficacy and safety profile of irbesartan\/amlodipine fixed-dose combination therapy compared with amlodipine monotherapy in hypertensive patients uncontrolled with amlodipine 5 mg monotherapy: A multicenter, phase III, prospective, randomized, open-label with blinded-end point evaluation study","author":"Bobrie","year":"2012","journal-title":"Clin Ther"},{"key":"key-10.4103\/0975-7406.206221-19","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2147\/VHRM.S4235","article-title":"Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: Update after recent clinical trials","author":"Reboldi","year":"2009","journal-title":"Vasc Health Risk Manag"},{"key":"key-10.4103\/0975-7406.206221-20","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.clinthera.2012.06.014","article-title":"Comparison of the efficacy and safety profiles of two fixed-dose combinations of antihypertensive agents, amlodipine\/benazepril versus valsartan\/hydrochlorothiazide, in patients with type 2 diabetes mellitus and hypertension: A 16-week, multicenter, randomized, double-blind, noninferiority study","author":"Lee","year":"2012","journal-title":"Clin Ther"},{"key":"key-10.4103\/0975-7406.206221-21","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.amjmed.2008.09.038","article-title":"Combination therapy versus monotherapy in reducing blood pressure: Meta-analysis on 11,000 participants from 42 trials","author":"Wald","year":"2009","journal-title":"Am J Med"},{"key":"key-10.4103\/0975-7406.206221-22","first-page":"119","article-title":"Enalapril and atenolol in essential hypertension: attenuation of hypotensive effect in combination","author":"Wing","year":"1988","journal-title":"Clin Exp Hypertens"}],"container-title":["Journal of Pharmacy And Bioallied Sciences"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:13:43Z","timestamp":1787066023000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jpbs.JPBS_308_16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"alternative-id":["206221"],"URL":"https:\/\/doi.org\/10.4103\/jpbs.jpbs_308_16","relation":{},"ISSN":["0975-7406"],"issn-type":[{"value":"0975-7406","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}